Llwytho...
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma
Bone marrow plasmacytoid dendritic cells (pDCs) in patients with multiple myeloma (MM) promote tumor growth, survival, drug resistance, and immune suppression. Understanding the molecular signaling crosstalk among the tumor cells, pDCs and immune cells will identify novel therapeutic approaches to e...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Oncogene |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7132141/ https://ncbi.nlm.nih.gov/pubmed/32024967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1172-0 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|